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Hepatocellular carcinoma (HCC) is one of the most fatal cancers due to delayed diagnosis and lack of eﬀective treatment options.
Signiﬁcant exposure to Aﬂatoxin B1 (AFB1), a potent hepatotoxic and hepatocarcinogenic mycotoxin, plays a major role in liver
carcinogenesis through oxidative tissue damage and p53 mutation. The present study emphasizes the anticarcinogenic eﬀect
of Tridham (TD), a polyherbal traditional medicine, on AFB1-induced HCC in male Wistar rats. AFB1-administered HCC-
bearing rats (Group II) showed increased levels of lipid peroxides (LPOs), thiobarbituric acid substances (TBARs), and protein
carbonyls (PCOs) and decreased levels of enzymic and nonenzymic antioxidants when compared to control animals (Group I).
Administration of TD orally (300mg/kg body weight/day) for 45 days to HCC-bearing animals (Group III) signiﬁcantly reduced
the tissue damage accompanied by restoration of the levels of antioxidants. Histological observation conﬁrmed the induction of
tumour in Group II animals and complete regression of tumour in Group III animals. This study highlights the potent antioxidant
properties of TD which contribute to its therapeutic eﬀect in AFB1-induced HCC in rats.
1.Introduction
Hepatocellular carcinoma (HCC) is the most common type
of primary liver cancer and accounts for around 70% of
all liver cancers [1]. Various factors have been implicated
as risk factors in the pathogenesis of liver cancer, notably
food contaminated with aﬂatoxins, toxins produced by fungi
of the genus Aspergillus sp. (A. ﬂavus and A. parasiticus)
[2, 3]. However, oxidative stress has emerged as a key
player in the development and the progression of liver
cirrhosis [4] which is known to be a precursor of HCC.
Both hepatitis B virus (HBV) and hepatitis C virus (HCV)
appear to be particularly more potent in inducing oxidative
stress, suggesting unique mechanisms that are activated by
these viral infections. AFB1 acts as a strong hepatotoxicant,
mutagen and naturally occurring hepatocarcinogen, which
cause liver cancer in a dose-dependent manner [5]. AFB1
is metabolized by cytochrome P450 enzymes to aﬂatoxin-
8,9 epoxide which is then detoxiﬁed by the glutathione S-
transferase system (GST). This reactive metabolite escapes
from the detoxiﬁcation process and usually conjugates with
DNA nucleotides forming adducts [6]. Such adducts are
responsible for the generation of observable AFB1 inducible
lethal mutation. AFB1 induces lipid peroxidation in rat liver,
and this may be an underlying mechanism of carcinogenesis
[7]. G to T transversion mutations in codon 249 of the p53
tumour-suppressor gene have been found in human liver
tumour from geographic areas with high risk of aﬂatoxin
exposure and in AFB1-induced liver toxicity [8].
Free radicals can be deﬁned as molecules or molecular
fragments containing one or more unpaired electrons in2 International Journal of Hepatology
atomic or molecular orbitals formed during a variety of bio-
chemical reactions and cellular functions. Reactive oxygen
s p e c i e s( R O S )a r ef r e er a d i c a l so fr e a c t i v ea n i o n sf o r m e db y
the incomplete one-electron reduction of oxygen including
singlet oxygen; superoxides; peroxides; hydroxyl radicals [9].
ROS have been incriminated in the pathophysiology of a
large number of diseases including coronary heart disease,
neurodegenerative disorders like Alzheimer’s disease, ageing,
and cancer [10–12]. Oxidative damage/stress results when
the level of ROS overpowers the system’s ability to neutralize
and eliminate them. Increased level of ROS usually results
from lack or functional disturbance in antioxidant molecules
or due to overproduction of ROS from the surrounding
environment [13]. Recent studies show that ROS also have
a role in cell signaling, including apoptosis, gene expression
and the activation of cell signaling cascades [14].
Free radicals can cause damage in structural and
metabolic components like lipids, proteins, enzymes, car-
bohydrates and DNA in cells and tissues. This ultimately
results in membrane damage, fragmentation, or random
cross-linkingofmoleculeslikeDNA,enzymes,andstructural
proteins and even lead to cell death induced by DNA frag-
mentation,lipidperoxidationandﬁnallytocancerformation
[15]. Aerobic organisms have well-developed mechanisms
to eﬃciently neutralize the oxidative eﬀects of oxygen
and its reactive metabolites. These self-sustained protective
componentsareclassiﬁedasthe“antioxidantdefensesystem”
The sensitive balance between prooxidant and antioxidant
forces in the body appears to be crucial in determining
the state of health and well-being [16]. Under normal
conditions, there is a balance between both the activities and
the intracellular levels of these antioxidants. This balance
is essential for the survival of organisms and their health
[17]. Cumulative eﬀect of the antioxidant defense system
eﬀectively removes the excess levels of prooxidants keeping
the pro- to antioxidant ratio in an equilibrium state. Any loss
in the functional activity of the major antioxidants leads to
disruption in the prooxidant to antioxidant ratio, creating
oxidative stress, and then cell damage ultimately favoring the
process of carcinogenesis [18]. When the antioxidant system
fails to counteract the increased productivity of ROS during
pathological conditions, it results in oxidative stress and this
is a preliminary event in the cancer initiation [13]. Supple-
mentation of antioxidant rich diet is often recommended as
part of cancer prevention [19]. There is a well-documented
association between increased consumption of antioxidants
and decreased incidence of cancer [20].
Tridham(TD)isapolyherbalformulationofthreeingre-
dients, Terminalia chebula seed coat, Elaeocarpus ganitrus
fruits, and Prosopis cineraria leaves in equal proportion
routinely used by the traditional Indian medicinal practi-
tioners in the treatment of cancer. Terminalia chebula is a
multipurpose herbal with excellent antibacterial [21], anti-
fungal,antiviral[22],anticarcinogenic[23],antianaphylactic
[24], antidiabetic [25], and antioxidant [26]p r o p e r t i e s .
Elaeocarpus ganitrus commonly known as Rudraksha in
India is grown in Assam and the Himalayan regions of India
for medicinal properties [27]. It has excellent free radical
scavenging eﬀectinrats[28]. Besides, it is reported to exhibit
multifarious pharmacological activities that include anti-
inﬂammatory [29], analgesic, sedative [30], antidepressant,
antiasthmatic [31], hypoglycemic [32], antihypertensive
[33], and smooth muscle relaxant [34]. Prosopis cineraria
(Syn. P. spicigera L.) possesses antibacterial, antifungal,
antiviral, and several other pharmacological properties [35].
The smoke of the leaves is considered good for eye ailments.
Leaves of P. cineraria are rich in phytochemical constituents
like alkaloids, namely, spicigerine; steroids, namely, campes-
terol, cholesterol, sitosterol, stigmasterol; alcohols namely
octacosanol and triacontan-1-ol; and alkane hentriacontane
[36].
The qualitative chemical exposition studies (data not
shown) on TD showed the presence of various beneﬁcial
phytochemicals such as ﬂavonoids, tannins, alkaloids, and
polyphenols. A known compound 3,4,5-trihydroxybenzoic
acid (Gallic acid) has been isolated through column chro-
matography and elucidated by a series of experiments,
involving NMR, IR, MS, and single-crystal X-ray crystallog-
raphy (XRD)(unpublished data). The isolated Gallic acid is
a well known polyhydroxyphenolic compound that can be
found in various natural products.
Despite innumerable studies indicating the utility of
individual medicinal herbs in the treatment of various
clinical manifestations, their application in cancer manage-
ment is still in its initial phase. With innumerable clinically
relevant active principles enriched in each component,
TD is a herbal preparation with promise in combating
the progression of cancer. The present study is aimed at
evaluating the antioxidant potential of TD in overcoming
oxidative damages associated with AFB1-instigated HCC in
male Wistar albino rats.
2.MaterialsandMethods
2.1. Materials
2.1.1. Animals and Diet. Male albino rats of Wistar strain,
8–10 weeks of age (120–150g), were used in this study.
The animals were obtained from Central Animal House
Facility, Dr. ALM PG IBMS, University of Madras, Taramani,
Chennai, India. The animals were housed in polypropy-
lene cages under a controlled environment with 12±1h
light/dark cycles and a temperature between 27 and 37◦C
and were fed with standard pellet diet (Gold Mohor rat feed,
M/s. Hindustan Lever Ltd., Mumbai) and water ad libitum.
All experiments involving animals were conducted according
to NIH guidelines, after obtaining approval from the insti-
tute’s animal ethical committee (IAEC no. 06/012/08).
2.1.2. Chemicals. AFB1 was procured from Sigma Chemical
Co., St. Louis, MO. It was dissolved in dimethyl sulphox-
ide (DMSO) immediately before administration. All other
chemicals used were of highest purity and analytical grade.
2.1.3. TD Preparation and Dose Determination. TD drug
is a combination of Terminalia chebula seed coats (fam-
ily: Combretaceae), dry seeds of Elaeocarpus ganitrusInternational Journal of Hepatology 3
(Syn. E. sphaericus) (family: Elaeocarpaceae) and Prosopis
cineraria leaves (Syn. P. spicigera L.) (family: Leguminosae).
The three ingredients were collected and given to the
Department of Centre for Advance Study (CAS) in Botany,
University of Madras, Guindy Campus, Chennai, India for
botanical authentication. The assigned herbarium numbers
are CASBH-16: Terminalia chebula, CASBH-17: Elaeocarpus
ganitrus,CASBH-18:Prosopiscineraria.TheIngredientswere
washed, air-dried in shade, and then ﬁnely ground. The
componentswerethenmixedinequalproportionsonweight
basis to get TD mixture. The extract of TD was prepared in
3:1 (v/w) ratio by adding 30mL of water to 10 grams of
combined TD and mixed well. The mixture was mixed by
using a shaker for 12 hours. The mixture was subsequently
ﬁltered using ﬁlter paper, and the clear ﬁltrate (aqueous
extract) was collected in a beaker. The ﬁltrate was then
lyophilized under vacuum pressure to yield a powder. The
lyophilized extract was stored in airtight containers in a dry
dark place.
The dose of TD used, that is, 300mg/kg body weight/day,
was decided upon after carrying out a dose-dependent study.
Acute toxicity studies showed no mortality and sub-acute
toxicity studies showed no signiﬁcant changes in histopatho-
logical, hematological, and biochemical parameters. Based
on these studies, we carried out a dose-dependent study
at doses of 50, 100, 200, 300, 400mg/kg body weight/day.
The results of this study revealed that the lowest possible
eﬀective dose was 300mg/kg body weight as evidenced by
histopathological observations, a signiﬁcant (P<0.05) in-
crease in body weight and a signiﬁcant (P<0.05) reduc-
tion in the levels of marker enzymes in serum and liver
(Unpublished data). The duration of treatment, that is, 45
days is the duration used by Siddha (a traditional Indian
system of medicine) physicians for treating HCC patients
utilizing the formulation TD. Thus the optimum dose of TD
was found to be 300mg/kg body weight/day for 45 days, and
this dose was used for all the subsequent experiments.
2.1.4. Experimental Design. Animals were divided into fol-
lowing four groups of six animals each. AFB1 was freshly
prepared by dissolving in dimethyl sulphoxide (DMSO)
before administration.
Group I. Normal control animals
Group II. HCC was induced in these animals by a
single intra-peritoneal dose of AFB1 (2mg/kg body
weight) [37].
Group III. HCC-induced animals (as in Group II)
were administered with the drug, TD (300mg/kg
body weight/day) orally for 45 days.
Group IV. Drug control animals received the same
dosage of TD as in Group III animals.
On the completion of the experimental period, animals
were sacriﬁced by cervical decapitation between 8:00 and
10:00h to avoid any possible rhythmic variations in the
antioxidant enzyme level. Blood was collected. Liver and
kidney were simultaneously removed, washed with ice-cold
saline. The organs were weighed, and one portion of each of
these organs was ﬁxed in 10% formalin for histopathological
examinations. 10% homogenate was prepared with fresh
tissue in 0.01M Tris-HCl buﬀer (pH 7.4). The resultant
supernatant was then used for biochemical assays.
2.2. Methods
2.2.1.BiochemicalInvestigations. Totalproteinwasestimated
by the method of Lowry et al. [38] using bovine serum
albumin (BSA) as the standard. LPO was measured by the
method of Devesagayam and Tarachand [39]. The TBARs
were estimated as per the spectrophotometric method
described by Ohkawa et al. [40]. PCOs were measured by
the method of Reznick and Packer [41]. SOD was assayed
by the method of Marklund and Marklund [42]. CAT was
assayed by the method of Sinha [43]. Glutathione peroxidase
(GPx) was assayed by the method of Rotruck et al. [44].
GSH was determined by the method of Moron et al. [45].
Vitamin E was estimated by the method of Quaife and Dju
[46]. Vitamin C was estimated by the method of Omaye et al.
[47].
2.2.2. Statistical Analysis. T h ev a l u e sa r ee x p r e s s e da sm e a n
± SD for six rats in each group. Statistically signiﬁcant
diﬀerences between the groups were calculated using one-
way analysis of variance (ANOVA) employing statistical
package for social sciences (SPSS). Values of P<0.05 were
considered to be signiﬁcant.
2.2.3. Gross Morphology and Histopathological Studies. Por-
tions of tissues were then ﬁxed in 10% neutral buﬀered
formalin, routinely processed, and embedded in paraﬃn
wax. Consecutive sections were cut at a thickness of 3-4µm
and subsequently stained with hematoxylin and eosin [48].
3. Results
3.1.MacromolecularDamage. Tables 1and2depictthelevels
of LPO, TBARs, and PCO in liver and kidney of control
and experimental animals. There was a signiﬁcant increase
in LPO, TBARs, and PCO in the HCC-induced (Group II)
animals.Thelevelsoftheseparameterswererestoredtonear-
normal levels on treatment with TD in Group III animals.
3.2. Antioxidants. The enzymic antioxidant activities of
SOD,CAT,andGPxintheserum,liver,andkidneyareshown
in Figures 1, 2,a n d3, respectively. From these ﬁgures, it
is evident that the activities of enzymic antioxidants were
signiﬁcantly decreased in AFB1-induced animals (Group II).
HCC bearing animals receiving TD treatment (Group III)
attained a near-normal level of enzymic antioxidant activ-
ities. The levels of antioxidant enzymes remained constant
without showing any signiﬁcant change in Group IV drug
control animals.
The levels of nonenzymic antioxidants like vitamin C,
vitamin E, GSH, total thiols (TTs), and nonprotein thiols
(NPT) in the serum, liver, and kidney are depicted in4 International Journal of Hepatology
Table 1: Eﬀect of TD on indicators of macromolecular damage in liver of control and experimental animals.
Parameters Group I (control) Group II (AFB1 induced) Group III (AFB1 induced + TD) Group IV (TD alone)
Lipid peroxides (LPO) 51.64 ± 5.62 79.41 ±9.26a∗ 53.15 ±6.14b∗ 50.44 ±5.02cNS
Thiobarbituric acid reactive
substances (TBARSs) 3.89 ±0.41 7.74 ±0.73a∗ 4.25 ±0.49b∗ 3.93 ±0.38cNS
Protein carbonyls (PCOs) 6.13 ±0.57 14.75 ±1.78a∗ 8.31 ±0.89b∗ 5.96 ±0.64cNS
Units. LPO: nmoles of MDA formed/mg protein, TBARS: nmoles/100g tissue, protein carbonyl: nmoles of DNPH formed/min/mg protein. Values are
expressed as mean ± SD for six animals. Comparisons are made between “a” Group II versus Group I, “b” Group III versus Group II, “c” Group IV versus
Group I. The symbol ∗represents the statistical signiﬁcance at P<0.05. NS: nonsigniﬁcant.
Table 2: Eﬀect TD on indicators of macromolecular damage in kidney of control and experimental animals.
Parameters Group I (control) Group II (AFB1 induced) Group III (AFB1 induced + TD) Group V (TD alone)
Lipid peroxides (LPO) 46.87 ± 3.62 68.17 ±6.38a∗ 48.53 ± 5.21b∗ 45.87 ±4.76cNS
Thiobarbituric acid reactive
substances (TBARSs) 3.13 ±0.37 7.39 ±0.69a∗ 3.95 ±0.44b∗ 3.18 ±0.35cNS
Protein carbonyls (PCOs) 5.53 ±0.59 11.61 ±1.31a∗ 6.14 ±0.69b∗ 5.56 ±0.61cNS
Units: LPO: nmoles of MDA formed/mg protein, TBARS: nmoles/100g tissue, protein carbonyl: nmoles of DNPH formed/min/mg protein. Values are
expressed as mean ± SD for six animals. Comparisons are made between “a” Group II versus Group I, “b” Group III versus Group II, “c” Group IV versus
Group I. The symbol ∗represents the statistical signiﬁcance at P<0.05. NS: nonsigniﬁcant.
a∗
a∗
a∗
b∗
b∗
b∗
cNS
cNS
cNS
0
10
20
30
40
50
60
70
80
90
Group I Group II Group III
U
n
i
t
s
Group IV
SOD
CAT
GPx
Figure 1: Eﬀect of TD on enzymic antioxidants in serum of control
and experimental animals. Values are expressed as mean ± SD for
six animals. Comparisons are made between “a” Group II versus
Group I, “b” Group III versus Group II, “c” Group IV versus Group
I. The symbol ∗represents the statistical signiﬁcance at P<0.05
NS: nonsigniﬁcant. SOD: U/min/mg protein, CAT: µmoles of H2O2
consumed/min/mg protein, GPx: µmoles of GSH oxidized/min/mg
protein.
Tables 3, 4,a n d5. Similar to enzymic antioxidant status,
the levels of non-enzymic antioxidants were also decreased
signiﬁcantlyinHCCanimals(GroupII),whichwerereverted
to near-normal levels after treatment with TD in Group III
animals. No signiﬁcant variation in the level of non-enzymic
antioxidants was noted in Group IV drug control animals.
3.3. Gross Morphology and Histopathology. Grossly, liver
tissue of Group II animals (AFB1 induced) showed whitish
nodular tumours of varying sizes in the liver (Figure 4(a)).
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Figure 2: Eﬀect of TD on enzymic antioxidants in liver of control
and experimental animals. Values are expressed as mean ± SD for
six animals. Comparisons are made between “a” Group II versus
Group I, “b” Group III versus Group II, “c” Group IV versus Group
I. The symbol ∗represents the statistical signiﬁcance at P<0.05.
NS: nonsigniﬁcant. SOD: U/min/mg protein, CAT: µmoles of H2O2
consumed/min/mg protein, GPx: µmoles of GSH oxidized/min/mg
protein.
Microscopically, Group I control animals showed liver
tissue with normal histology (Figure 4(b)). The liver of
Group II (AFB1 induced) animals was inﬁltrated by hyper-
chromatic pleomorphic tumour cells arranged in a tra-
becular pattern in some areas and in sheets and nests in
other areas. Numerous mitotic ﬁgures including atypical
mitoses were seen. Some of the tumour cells showed
markedlyenlarged,bizarrenuclei(Figure 4(c)).Theadjacent
normal liver cells showed nodularity and dysplastic features
(Figure 4(d)). Group III (AFB1 induced TD treated) liver
showed normal histology. There was no evidence of tumour
(Figure 4(e)). Group V (TD alone) liver showed normal
morphology and architecture (Figure 4(f)).International Journal of Hepatology 5
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Figure 3:EﬀectofTDonenzymicantioxidantsinkidneyofcontrol
and experimental animals. Values are expressed as mean ± SD for
six animals. Comparisons are made between “a” Group II versus
Group I, “b” Group III versus Group II, “c” Group IV versus Group
I. The symbol ∗represents the statistical signiﬁcance at P<0.05.
NS: nonsigniﬁcant. SOD: U/min/mg protein, CAT: µmoles of H2O2
consumed/min/mg protein, GPx: µmoles of GSH oxidized/min/mg
protein.
4. Discussion
LPOisawell-recognizedpreliminaryeventofoxidativedam-
age of plasma membrane and initiation of carcinogenesis
[49]. The formation of the metabolite, AFB1-8,9-epoxide,
causes membrane damage through lipid peroxidation and
subsequent covalent binding to DNA to form AFB1-DNA
adducts. These are critical steps leading to hepatocarcino-
genesis [50]. There was a signiﬁcant reduction in the level
of lipid peroxides upon treatment with TD in tumour-
bearing animals which have been mainly attributed to the
components of TD. Aqueous extract of T. chebula at a
concentration of 15µg/mL shows 50% inhibition in LPO
activity [51]. A report by Suchalatha and Devi [52]s t r o n g l y
indicate a protective role of T. chebula against membrane
damage by prevention of peroxide radical formation and
MDA formation in isoproterenol-induced oxidative stress in
rats. E. ganitrus acts as a potent iron chelator with 76.70%
inhibition at a concentration of 500µg/mL. Metal chelating
agents reduce the concentration of catalyzing transition
metals by forming sigma bonds and reducing the redox
potential, thereby stabilizing the oxidized form of the metal
ion [53]. Malon dialdehyde acts as an important contributor
to the increase in protein carbonyl content observed during
the oxidation of protein/polyunsaturated fatty acid mixtures
[54]. Dietary antioxidant and polyphenols act against ROS
thereby indirectly reducing the PCO content [55]. The
inhibitory eﬀects of PCO by TD may be attributed to the
presenceofvariousbioactivecomponentssuchasﬂavonoids,
alkaloids, and polyphenols that act as antioxidants by scav-
enging chain-propagating, reactive free radicals generated by
AFB1.
The reducing capacity of a compound serves as a
signiﬁcant indicator of its potential antioxidant activity.
Levels of enzymic antioxidants were signiﬁcantly decreased
in HCC-bearing animals as these are consumed for reducing
prooxidants. Supplementation of TD to tumour-bearing
animals restored the level of diﬀerent antioxidants, eﬀec-
tively. Flavonoids have been shown to act as scavengers of
various oxidizing species, such as hydroxyl radicals, peroxy
radicals, or superoxide anions, due to the presence of a
catechol group in the B-ring and the 2,3 double bond in
conjunction with the 4-carbonyl group as well as the 3- and
5-hydroxyl groups [56, 57]. Flavonoids have been proved to
be potent inhibitors of enhanced spontaneous production of
both MDA and conjugated dienes [58]. Antioxidant activity
of TD results mainly from ellagic acid, 2,4-chebulyl-b-D-
glucopyranose, chebulinic acid, casuarinin, chelani, and 1,6-
di-O-galloyl-b-D-glucose which have been reported to be
active constituents in T. chebula fruits [23, 26]. Aqueous
extract of fruit of T. chebula should strengthen antioxidant
properties, presenting tert-butyl hydroperoxide- (t-BHP-)
induced oxidative injury observed in cultured rat primary
hepatocytes and rat liver [59]. Glutathione peroxidase (GPx)
is considered as a major defence against peroxides, superox-
ide anion, and hydrogen peroxide and assumes an important
role in detoxifying lipid and hydrogen peroxide with the
concomitant oxidation of glutathione [60]. Phytochemicals
present in T.c h e b u l amay contribute to restoration of GPx
activity by TD treatment observed in this study. These
antioxidant activities of TD are based on hydrogen donation
abilities and chelating metal ions.
GSH plays a major role in the detoxiﬁcation of xeno-
biotic compounds [61]. The high levels of ﬂavonoids and
phenolic compounds present in components of TD have
been reported to have the capacity to increase GSH levels,
modifying its redox rate and actively, participating in the
eliminating of AFB1 metabolite [62]. Sharma et al. [63]
have reported that phenolic compounds are found to be
inducers of GSH. Gallic acid, a polyphenol, is one of the
hepatoprotective active principles isolated from TD that may
augment GSH levels. Vitamin C is one of the most eﬀective
biological antioxidants, and it has been shown that vitamin
C supplementation can reduce risks of diseases associated
with oxidative stress, such as cancer [64]. Among the factors
modifying oxidative stress, there is strong interest in the
antioxidant vitamins E and C, the intake of which can be
easily and safely controlled through the diet. Vitamin C
protects cells mainly against ROS such as superoxide anion
radical, hydroxyl oxygen radical, hydrogen peroxide, and
singlet oxygen [65]. It is the most signiﬁcant antioxidant
that can protect against carcinogenesis and tumour growth.
A decreased level of vitamin E content might be due to
the excessive utilization of this antioxidant for quenching
the enormous quantity of free radicals produced in these
conditions.AccordingtoHazraetal.[66]T. chebula isknown
for its natural antioxidant property due to its content of
vitamins C. Thus, vitamin C and E could act synergistically
in scavenging a wide variety of ROS. Thiols are water-soluble
antioxidants linked to membrane proteins and are essential
for the antioxidant system. AFB1 administration causes the
reduction of thiol levels [67]. Both total and nonprotein
thiols were decreased in AFB1-induced HCC conditions.
Due to the antioxidant and free radical quenching nature of6 International Journal of Hepatology
Table 3: Eﬀect of TD on non enzymic antioxidants and thiols in serum of control and experimental animals.
Parameters Group I
(control) Group II (AFB1 induced) Group III
(AFB1 induced + TD) Group IV (TD alone)
Vitamin C 2.83 ±0.29 0.99 ±0.01a∗ 2.87 ±0.28b∗ 2.85 ±0.31cNS
Vitamin E 2.43 ±0.28 1.09 ±0.19a∗ 2.38 ±0.27b∗ 2.45 ±0.26cNS
Total thiols (TSHs) 5.16 ±0.59 3.07 ±0.39a∗ 5.09 ±0.51b∗ 5.17 ±0.53cNS
Non protein thiols (NPSHs) 4.89 ±0.51 1.69 ±0.19a∗ 4.66 ±0.51b∗ 4.97 ±0.52cNS
Reduced glutathione (GSH) 24.68 ±2.92 9.45 ±1.67a∗ 23.35 ±3.16b∗ 24.63 ±2.67cNS
Units: GSHmg/100g tissue, Vitamins C and Emg/dL tissue, TSH and NPSH: µg/mg protein. Values are expressed as mean ± SD for six animals. Comparisons
are made between “a” Group II versus Group I, “b” Group III versus Group II,“c” GroupIV versus GroupI. The symbol ∗represents the statisticalsigniﬁcance
at P<0.05. NS: nonsigniﬁcant.
Table 4: Eﬀect of TD on nonenzymic antioxidants and thiols in liver of control and experimental animals.
Parameters Group I
(control) Group II (AFB1 induced) Group III (AFB1 induced + TD) Group IV (TD alone)
Vitamin C 3.93 ±0.49 1.95 ±0.27a∗ 3.69 ±0.43b∗ 4.11 ±0.51cNS
Vitamin E 2.54 ±0.35 1.36 ±0.17a∗ 2.38 ±0.28b∗ 2.45 ±0.31cNS
Total thiols (TSHs) 9.42 ±1.13 4.68 ±0.56a∗ 8.81 ±1.14b∗ 9.31 ±1.11cNS
Non protein thiols (NPSHs) 5.58 ±0.66 2.15 ±0.25a∗ 5.31 ±0.68b∗ 5.44 ±0.65cNS
Reduced glutathione (GSH) 32.31 ±4.21 18.34 ±2.77a∗ 29.73 ±4.75b∗ 33.83 ±4.17cNS
Units:GSHmg/100gtissue,VitaminCandEmg/gwettissue,TSHandNPSH:µg/mgprotein.Valuesareexpressedasmean ±SDforsixanimals.Comparisons
are made between “a” Group II versus Group I, “b” Group III versus Group II,“c” GroupIV versus GroupI. The symbol ∗represents the statisticalsigniﬁcance
at P<0.05. NS: nonsigniﬁcant.
Table 5: Eﬀect of TD on nonenzymic antioxidants and thiols in kidney of control and experimental animals.
Parameters Group I (control) Group II (AFB1induced) Group III (AFB1 induced + TD) Group IV (TD alone)
Vitamin C 2.94 ±0.38 1.52 ±0.22a∗ 2.78 ±0.35b∗ 2.95 ±0.37cNS
Vitamin E 2.85 ±0.29 1.12 ±0.17a∗ 2.42 ±0.27b∗ 2.91 ±0.31cNS
Total thiols (TSH) 7.17 ±1.14 2.88 ±0.33a∗ 6.85 ±0.78b∗ 7.79 ±0.81cNS
Non protein thiols (NPSH) 4.75 ±0.61 2.68 ±0.34a∗ 4.31 ±0.51b∗ 4.68 ±0.56cNS
Reduced glutathione (GSH) 27.04 ±2.97 13.54 ±2.21a∗ 25.51 ±2.98b∗ 27.98 ±3.23 cNS
Units-GSH-mg/100g tissue, Vitamin C and E-mg/g wet tissue, TSH and NPSH: µg/mg protein. Values are expressed as mean ± SD for six animals.
Comparisons are made between “a” Group II versus Group I, “b” Group III versus Group II, “c” Group IV versus Group I. The symbol ∗represents the
statistical signiﬁcance at P<0.05. NS: nonsigniﬁcant.
TD, the thiol levels were resumed to near normal in drug-
treated animals. TD acts as potential antioxidant agent by
exerting its activity at various levels to reduce AFB1-induced
oxidativestressandeﬀectivelyquenchesfreeradicals,reduces
its formation, and increases the activity of diﬀerent antiox-
idant enzymes. Thus TD has a hepatoprotective eﬀect as
demonstrated by enhanced activity of antioxidant enzymes.
The redeeming action of TD in tumour-induced rats is most
probably due to additive and synergistic eﬀect of individual
components.
Compounds such as tannins are reported to be responsi-
ble for retrieval of vitamin C activity [68], whereas trigalloyl
glucose and ellagic acid [69] present in TD might strengthen
the soothing activity of the drug. We have evaluated the
antioxidant potential of TD by studying the combined
eﬀects of three ingredients derived from T. chebula, E.
ganitrus and P. cineraria in AFB1-induced liver cancer. The
active principles present in each component render TD a
potent antioxidant property. The therapeutic eﬀect of TD in
tumour-induced rats is most probably due to the synergistic
action of the constituents such as ﬂavonoids, alkaloids
and tannins. T. chebula contains the ﬂavonoids, gallic
acid, 1,2,3,4,6-penta-O-galloyl-b-D-glucopyranose, chebu-
lagic acid and chebulinic acid as well as vitamin C [70]. A
report from Ray et al. [71] reveals the presence of alkaloids,
glycosides, steroids, and ﬂavonoids in E. ganitrus. Malik and
Kalidhar[36]havereportedthepresenceoftannins,alkaloids
and steroids in Prosopis cineraria leaves. Thus TD has been
foundtoexhibithepatoprotectiveandanticarcinogeniceﬀect
asdemonstratedbyincreasedactivityofantioxidantenzymes
and total regression of tumour seen on histopathological
examination of the liver. In summary, the present study
providestheevidencethatTDhastherapeuticeﬀectinAFB1-
induced HCC. TD also reverses the free radical damageInternational Journal of Hepatology 7
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Figure 4: Eﬀect of TD on gross morphology and histopathology in liver of control and experimental animals. (a) Gross morphology of
Group II animals (AFB1 induced). (b) Liver tissue of Group I control animals (10X). (c) Liver tissue of Group II (AFB1 induced) animals
(40X). (d) Liver tissue of Group II (AFB1 induced) animals (40X). (e) Liver tissue of Group III (AFB1 induced + TD treated) animals (10X).
(f) Liver tissue of Group IV (TD treated) animals (10X).
brought about by administration of AFB1 by enhancing the
enzymatic and non enzymatic antioxidant defense mecha-
nisms.
5. Conclusion
The protection by TD against oxidative stress in AFB1-
mediatedHCCmighthasoccurredthroughmultipleactions,
which include prevention of LPO and stabilization of
antioxidant defense mechanism. These factors protect cells
from ROS damage in AFB1-induced HCC, as TD abolishes
the causative factors of liver injury and tumour markers by
decreasing LPO, the possible mechanism of AFB1 induction.
The strong antioxidant and therapeutic eﬀect of TD in
vivo might be due to the spectrum of synergistically active
phytomolecules present in TD. Elucidation of the exact
mechanism of action of the phytotherapeutic eﬀect of TD in
AFB1-induced HCC necessitates further studies.
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